EMA Authorised: Pergoveris (follitropin alfa;lutropin alfa) — Merck Europe B.V.

View source ↗

Summary

EMA authorised Pergoveris (follitropin alfa; lutropin alfa) by Merck Europe B.V. for female infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Pergoveris (follitropin alfa and lutropin alfa)

Snippet

Status: Authorised. Therapeutic area: Infertility, Female. MAH: Merck Europe B.V.. Decision date: 17/06/2025